Each uncoated chewable tablet contains:
Albendazole BP 400 mg
Colour: Ponceau 4R
Each 10 ml contains:
Albendazole BP 400 mg
Inactive Ingredients: Beldomax Tablet: Sugar, Starch, Methyl Paraben, Propyl Paraben, Purified Talc, Magnesium Stearate, Saccharin Sodium, Flavour Strawberry, Purified Water
Beldomax Suspension: Sucrose, Methyl Paraben, Propyl Paraben, Xanthan Gum, Colloidal Anhydrous Silica, Sodium Benzoate, Glycerine, Polysorbate 80, Citric Acid, Liquid Sorbitol, Disodium Edetate, Flavour Pineapple, Purified Water
Beldomax is indicated in the treatment of single or mixed intestinal parasites. Beldomax is effective in the treatment of Ascaris lumbricoides, Strongyloides stercoralis (roundworm); Trichuris trichiura (whipworm); Enterobius vermicularis (pinworm/threadworm); Ancylostoma duodenale, Necator americanus (hookworm) and Taenia solium (tapeworm). Beldomax is also effective in the treatment of Giardiasis (duodenalis, intestinalis or lamblia) and Capillariasis in children.
Beldomax contains Albendazole which is a broad spectrum anthelmintic and works by killing sensitive parasites. Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin and inhibits microtubules polymerization. The systemic anthelmintic activity has been attributed to the primary metabolite, Albendazole sulfoxide. Albendazole is effective in clearing threadworms, pinworms, roundworms, whipworms, tapeworms and hookworms from the gut and other tissues. It kills these worms by starvation. The eggs, larvae and adult worms are also affected. Oral bioavailability appears to be enhanced when Albendazole is co-administered with a fatty meal. Maximal plasma concentrations of Albendazole sulfoxide are typically achieved in 2 to 5 hours after dosing. Albendazole sulfoxide is 70% bound to plasma protein and is widely distributed throughout the body. The mean apparent terminal elimination half-life of Albendazole sulfoxide typically ranges from 8 to 12 hours.
Beldomax is contraindicated in conditions of Anaemia, Cirrhosis, Bone marrow failure and to patients with known hypersensitivity to Albendazole.
Beldomax may rarely cause Abdominal pain, Dizziness, Headache, Fever, Nausea and Vomiting. Symptoms of side effects, if any, should subside after discontinuing the medicine.
If symptoms persist, please consult the physician.
Adults and Children above 2 years: 400 mg (1 tablet) or 10 ml (400 mg) suspension as a single dose Children 1-2 years: 5 ml (200 mg) suspension as a single dose. In heavy mixed infection involving Strongyloides or Taeniasis, the dose may be given for three consecutive days. If the patient is not cured after three weeks, a second course of treatment may be given.
Store in a cool, dark & dry place. Keep out of reach of children.
Tablet: 1 Tablet packed in a blister and 1 such blister packed in a carton with insert.
Suspension: 10 ml amber coloured PET bottle packed in a unit carton with insert.